FDA spurns hay fever drug from India's Glenmark
In its attempt to be transparent about manufacturing machinery, Indian drugmaker Glenmark appears to have shot itself in the foot with the FDA. On Saturday …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.